Jon E. Sprague
Department of Pharmaceutical & Biomedical Sciences
The Raabe College of Pharmacy
Ohio Northern University
Ada 45810
USA
Name/email consistency: high
- Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonists. Sprague, J.E., Brutcher, R.E., Mills, E.M., Caden, D., Rusyniak, D.E. Br. J. Pharmacol. (2004)
- UCP3 and thyroid hormone involvement in methamphetamine-induced hyperthermia. Sprague, J.E., Mallett, N.M., Rusyniak, D.E., Mills, E. Biochem. Pharmacol. (2004)
- Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy). Sprague, J.E., Banks, M.L., Cook, V.J., Mills, E.M. J. Pharmacol. Exp. Ther. (2003)
- Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning. Sprague, J.E., Preston, A.S., Leifheit, M., Woodside, B. Physiol. Behav. (2003)
- In vivo microdialysis and conditioned place preference studies in rats are consistent with abuse potential of tramadol. Sprague, J.E., Leifheit, M., Selken, J., Milks, M.M., Kinder, D.H., Nichols, D.E. Synapse (2002)
- The pharmacodynamic characterization of an antisense oligonucleotide against monoamine oxidase-B (MAO-B) in rat brain striatal tissue. Sprague, J.E., Worst, T.J., Haynes, K., Mosler, C.R., Nichols, D.E., Kane, M.D. Cell. Mol. Neurobiol. (2001)
